Psoriasis is a chronic inflammatory skin disease for which long-term treatment adherence is essential to achieve and maintain disease control. However, adherence remains suboptimal in routine clinical practice. While a range of interventions have been developed to support adherence, variability in intervention design and outcome reporting has limited the ability to draw clear conclusions regarding their effectiveness. This systematic review aimed to evaluate interventions designed to improve treatment adherence among patients with psoriasis, to synthesise evidence on adherence outcomes as well as associated clinical and patient-reported effects. A systematic literature search was conducted across major electronic databases in accordance with PRISMA guidelines to identify studies assessing adherence-enhancing interventions in psoriasis. Twenty-six studies were included. Digital and technology-supported interventions, including mobile applications, short message service reminders and electronic monitoring-supported platforms were the most frequently evaluated and were generally associated with modest improvements in adherence when compared to usual care. Healthcare professional-led interventions such as nurse and pharmacist delivered models demonstrated potential benefits in adherence. Across studies, improvements in adherence were more consistently observed than improvements in clinical severity and quality-of-life outcomes. Substantial heterogeneity in intervention design, adherence measurement and follow-up duration precluded quantitative synthesis. This systematic review highlights the diversity of approaches used to address treatment adherence benefits. However, inconsistent effects on clinical outcomes and methodological heterogeneity underpin the need for standardised adherence measures, longer term follow-up and further evaluation of scalable, multidisciplinary adherence support strategies.
Kumar et al. (Fri,) studied this question.